Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Newest BOD additions:
Bruce Colclasure, Bristow, OK, is the owner of the Flying C Bar Ranch and Patriot Sales and Productions, LLC. He is a lifetime active member and a 4A Judge of the National Cutting Horse Association (NCHA), founding member, judge’s director and an active member and committee member of the United States Cutting Horse Association (USCHA) and former LiveStock Impact Division President. Bruce Colclasure is proud of these lifetime credentials but what he prides himself of the most is the accomplishments in the different equine disciplines. Bruce himself has won and trained multiple World Champions as well as having a successful breeding program. He attributes a large part of his success to a fine-tuned nutrition program that makes his horses shine brighter in and out of the arena.
Charles Timmerman, D.V.M. , a graduate of Georgia University School of Veterinary Medicine, established a veterinary clinic in 1973 in Aiken, SC, to offer care for small and large animals. Besides providing comprehensive clinical care, he has utilized a large network of veterinary specialists and laboratories to help create innovative products and test new methods for the management of various animal health problems. After his recent retirement from clinical practice, Dr. Timmerman has continued to follow a variety of research interests including advanced technologies for the diagnosis and treatment of animal vitamin deficiencies. During the past decade, Dr. Timmerman has been a central contributor of scientific and clinical guidance aimed at developing breakthrough animal health products, leading to the emergence of the LiveStock Impact Division and the eventual evolution into the wholly owned subsidiary, LiveStock Impact, Inc. He has helped design and execute numerous animal tests and has provided critical oversight to identify product efficacy and ensure product safety.
U.S. Equestrian Foundation and American Horse Counsel surveys show approximately 7 million horses and over 6 million owners, workers and other service providers in the US involved in recreation, racing, and showing. Equine business has a total annual GDP impact of over $100 billion and over $38 billion spent directly on goods and services relating to equine care. International markets, especially in the Middle East, exceed domestic figures by significant amounts. Our target market is well-defined and exceptionally resistant to economic downturns. True horse people take care of their animals regardless of what is going on elsewhere.
BIOADAPTIVES PRODUCT ROLL-OUT: LIVESTOCK IMPACT™ EQUINE ALL-IN-ONE™ INTRODUCED AT SHAWNEE SPRING HORSE SALE 6-16-20
Bruce Colclasure, new board director of future spin-off BioAdaptives® LiveStock Impact™, a well-known and successful livestock nutritionist, breeder, competitor, winner, and owner of numerous champion horses commented “This marks the first of a full line of natural, effective and cost-friendly wellness supplements that will complement each livestock nutrition program. Our Equine Regen Plus® has performed with remarkable success in the past six years. We have now expanded this to provide products that are able to nourish every cell in your livestock’s body with supplements from the earth that are minimally processed, mostly plant-based, and naturally packed with essential nutrients and powerful antioxidants that will help livestock look, feel, and perform at their best. We are excited to continue to offer parallel products to promote wellness and performance in companion pets and other shown animals.”
BIOADAPTIVES PRODUCT ROLL-OUT: LIVESTOCK IMPACT™ EQUINE ALL-IN-ONE™ INTRODUCED AT SHAWNEE SPRING HORSE SALE 6-16-20
"We believe that the proceeds of this offering will satisfy our cash requirements for at least the next
twelve months." (Top line of page 23)
http://pdf.secdatabase.com/181/0001477932-23-007567.pdf
Thanks for your DD, PB. Much appreciated.
You've made your points. All of us still holding are fools. We can live with that.
"We believe that the proceeds of this offering will satisfy our cash requirements for at least the next twelve months." (pg 23)
Hasn't been announced yet. If it had been announced, price would be way higher.
As an innocent bystander, I am asking that you please keep your "guns" holstered. There are lots of reasons to feel both bullish and bearish on this stock. That's the OTC in a nutshell.
There have been a lot of accusations flying around this board recently. Perhaps that's inevitable when times get tough. Clearly, we're all a bit restless at this point. Patience is a virtue for a reason. Bottom line, we're all here for the same reason - to make 💲 - so let's all try our best to not cut off our noses to spite our faces.🙂
The delay in sharing spinoff details is likely due to moving over Dr. Yagang Liu and Dr. David Allen to the Livestock Board. Spinoff details should follow soon imo. But what do I know?😁
New PR out. Not sure if it will have much of an impact. We'll see.
https://www.stocktitan.net/news/BDPT/bio-adaptives-inc-redefines-its-expanding-role-of-providing-1zl2gc57zvec.html
Safe travels, PB! We'll hold down the fort!🙂
The reason for the improvement in post behavior this week is obvious.
Robert Ellis, President and Director, brings more than forty years of business management experience to the Company. He has worked extensively in senior positions across a variety of industry disciplines, including aerospace, electronics, communications, and international marketing. Mr. Ellis has been an executive officer in private and public companies, both major entities, start-ups, and emerging entities. He has an Accounting Degree from the University of Illinois, and is a CPA.
Charles Townsend, COO and Director, brings over 30 years of experience in operations and enterprise marketing to the BioAdaptives team. Mr. Townsend has a Bachelor of Arts degree in accounting from the University of Texas and an MBA from the University of North Texas.
DR. TED - CEO - Board Chairman
Dr. Edward E. Jacobs, Jr. (Dr. Ted), a graduate of Princeton University and Harvard Medical school, is a biotechnology consultant with over 25 years of experience in biopharmaceutical and medical device development, as well as 35 years of teaching and direct patient care.
Dr. Ted has participated in drug development processes, from discovery through animal and human studies, including regulatory support for FDA, and international regulatory affairs, strategic planning,
and investor relations.
Dr. Ted has extensive clinical operations experience, having executed more than 15 human trials in the U.S., Europe, and South Africa. He has also served as a Medical Monitor and Liaison for clinical investigators involved with international trials, with responsibility for regulatory compliance.
In his research, Dr. Ted has made original observations in the field of artificial blood, tissue oxygenation therapy, and water modification. His current focus is on natural products for human and animal use, anti-aging strategies, and primitive cell biology. He is an author of more than 40 scientific publications, and is the holder of 4 patents.
Board member David Allen, PhD, is a visionary futurist and wellness pioneer. He is CEO of World Wellness and co-founder and President of the American Botanical Drug Association. He has developed a value web network of influential people in various nations during the course of his many life journeys in education, philosophy, science and business.
He teaches that the future of health and wellness, life extension and life enhancement will be based on the integration of principles of ancient and modern healing systems, whole food plant-based nutrition and the latest scientific advances in biotech, nanotechnology, neuro cognitive enhancement, stem cell research, quantum science and artificial intelligence.
https://www.botanicaldrug.org/
Newest BOD additions:
Bruce Colclasure, Bristow, OK, is the owner of the Flying C Bar Ranch and Patriot Sales and Productions, LLC. He is a lifetime active member and a 4A Judge of the National Cutting Horse Association (NCHA), founding member, judge’s director and an active member and committee member of the United States Cutting Horse Association (USCHA) and former LiveStock Impact Division President. Bruce Colclasure is proud of these lifetime credentials but what he prides himself of the most is the accomplishments in the different equine disciplines. Bruce himself has won and trained multiple World Champions as well as having a successful breeding program. He attributes a large part of his success to a fine-tuned nutrition program that makes his horses shine brighter in and out of the arena.
Charles Timmerman, D.V.M. , a graduate of Georgia University School of Veterinary Medicine, established a veterinary clinic in 1973 in Aiken, SC, to offer care for small and large animals. Besides providing comprehensive clinical care, he has utilized a large network of veterinary specialists and laboratories to help create innovative products and test new methods for the management of various animal health problems. After his recent retirement from clinical practice, Dr. Timmerman has continued to follow a variety of research interests including advanced technologies for the diagnosis and treatment of animal vitamin deficiencies. During the past decade, Dr. Timmerman has been a central contributor of scientific and clinical guidance aimed at developing breakthrough animal health products, leading to the emergence of the LiveStock Impact Division and the eventual evolution into the wholly owned subsidiary, LiveStock Impact, Inc. He has helped design and execute numerous animal tests and has provided critical oversight to identify product efficacy and ensure product safety.
They really have assembled an impressive BOD with literally a couple centuries of combined years of experience in their chosen fields.
Within the past decade, LY Research, a company engaged in the development, manufacturing and marketing of botanical drug products and nutraceuticals in China, Europe, and the U.S, and its owner, Dr. Yaguang Liu have received 32 patents from the U. S. Patent and Trademark Office for safe natural botanicals, used for treatment of Alzheimer’s, Cardiovascular, Myopia and other conditions. Dr. Liu was born and educated in the People’s Republic of China. He graduated from Fudan University, Shanghai and had been a visiting Professor at the Department of Medicine of the University of Chicago. He established the Molecular Medicine Institute in China and was a director of this institute. He has authored four books: (1) An Investigation of the Combined Theories of Chinese and Western Medicines from the Angle of Molecular Biology; (2) Molecular Biology in Heart Disease; (3) Principles of Theoretical Medicine; and (4) Natural Science and the Theory of Chinese Medicine.
STRONG BUY CANDIDATE
BDPT stock price gained 15.61% on the last trading day, rising from $.0043 to $.0050. It has now gained 3 days in a row. The price has risen in 6 of the last 10 days and is up by 38.89% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign. The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current trend, the stock is expected to rise 158.06% during the next 3 months and, with a 90% probability, hold a price between $.0086 and $.0154 at the end of this 3-month period. Bioadaptives holds several positive signals. As the old saying goes, "Let the trend be your friend." We therefore consider it to be a good choice at these current levels and are expecting further gains during the next 3 months. We have upgraded our analysis for this stock since the last evaluation from a Buy to a Strong Buy candidate.
https://stockinvest.us/stock/BDPT
20 watchers on Stocktwits added in last 24 hours
CM has referenced the Shell Risk designation on OTC Markets as one of the reasons he's bearish.
The company has stated that they have written OTC Markets to have the designation removed, however, that might not happen for a little while.
According to OTC Markets:
"The Shell Risk designation indicates that a company displays characteristics common to Shell Companies. This designation is made at OTC Markets’ sole and absolute discretion based on an analysis of the company’s annual financial data and may differ from issuers’ self-reported shell classifications in their own public filings. Our analysis evaluates asset composition, operational expenditures, and income related metrics. No action is required by a company to perform the evaluation other than publishing current annual financial information.
In limited circumstances, OTC Markets will consider removal of a company’s Shell Risk designation upon written request by a company. Please be advised that such requests will only be considered when there has been a material change in financial condition since the most recent fiscal year-end that is reflected in publicly available interim financial statements. Examples include a material increase in asset composition or operating revenues with related financial disclosure as a result of an acquisition or change in control transaction."
As we know, with BDPT, there is no risk of Shell status, but there has also not been a substantial material increase in financial condition, so it appears the Shell Risk status will remain for the time being.
U.S. Equestrian Foundation and American Horse Counsel surveys show approximately 7 million horses and over 6 million owners, workers and other service providers in the US involved in recreation, racing, and showing. Equine business has a total annual GDP impact of over $100 billion and over $38 billion spent directly on goods and services relating to equine care. International markets, especially in the Middle East, exceed domestic figures by significant amounts. Our target market is well-defined and exceptionally resistant to economic downturns. True horse people take care of their animals regardless of what is going on elsewhere.
BIOADAPTIVES PRODUCT ROLL-OUT: LIVESTOCK IMPACT™ EQUINE ALL-IN-ONE™ INTRODUCED AT SHAWNEE SPRING HORSE SALE 6-16-20
Bruce Colclasure, President of BioAdaptives® LiveStock Impact™ division, a well-known and successful livestock nutritionist, breeder, competitor, winner, and owner of numerous champion horses commented “This marks the first of a full line of natural, effective and cost-friendly wellness supplements that will complement each livestock nutrition program. Our Equine Regen Plus® has performed with remarkable success in the past six years. We have now expanded this to provide products that are able to nourish every cell in your livestock’s body with supplements from the earth that are minimally processed, mostly plant-based, and naturally packed with essential nutrients and powerful antioxidants that will help livestock look, feel, and perform at their best. We are excited to continue to offer parallel products to promote wellness and performance in companion pets and other shown animals.”
BIOADAPTIVES PRODUCT ROLL-OUT: LIVESTOCK IMPACT™ EQUINE ALL-IN-ONE™ INTRODUCED AT SHAWNEE SPRING HORSE SALE 6-16-20
If you're reacting to my post with the 10Q highlights, that was from the last 10Q in August. We're still in the 3rd quarter, so next 10Q would come out in mid-November.
Highlights from 10Q:
"Currently, other than the two equine formulations where we have the exclusive marketing rights, we do not own the formulations for our key products and manufacture and market them under an agreement with the developer that requires payment of a royalty and a license agreement. We are negotiating towards the acquisition of some of these formulations."
"...PluriPain® targeted toward the symptoms of Pre-menstrual syndrome and menstrual pain. Anecdotal and testimonial reports have long noted that users obtain relief from these symptoms with use of the PluriPain® product, and we have made adjustments and additions to the formulation to target these symptoms. Early reports are promising, and we expect marketing efforts to emphasize the usefulness of our product to alleviate PMS-related symptoms. By popular requests, the Company is also working with developers on a menopause supplement. "
" We started to re-launch our internet-based marketing activities in Q1 2023, extending the individual product websites, revamping the Company’s website, continuing to explore wholesale, white-label opportunities and placing products on Amazon."
"To expand our footprint on the Amazon sales channel, we are discussing with Amazon marketing specialist in third party management of our products on Amazon."
" ...exploring marketing prospects in Asia, Australasia, the Middle East, and Europe."
I posted information. Some people find value in that over petty snipes. In fact, right after I posted, someone who didn't read my post, asked if they would get dividends from the spinoff. Had they read my post, they wouldn't have needed to ask that. Keep sniping though. You fit right in with a number of posters on this board.
Clearly, another PR will follow in short order explaining how this spinoff will impact shareholders. Smart to withhold that info on a Friday. Let the excitement grow over the weekend. Go Lions! (long-suffering Detroiter)
How Spinoffs Are Created
A corporation creates a spinoff by distributing 100% of its ownership interest in that business unit as shares of stock to existing shareholders.
It can also offer its existing shareholders a discount to exchange their shares in the parent company for shares of the spinoff.
For example, an investor could exchange $100 of the parent’s stock for $110 of the spinoff’s stock. Spinoffs tend to increase returns for shareholders because the newly independent companies can better focus on their specific products or services.
Investopedia
Fake wall at .004 abandoned for now.
I didn't see any reference to the stickies or to PB in your post. All good. I was just reacting to the people thanking you for the DD. That said, you helped to spread PB's DD and that has value as well. Cheers!
Yeah boi!!!!!!!!
I agree about the team, but clearly PB spent a lot of time putting that all together. CJ was getting kudos for his work, and I felt the need to set the record straight. A simple "props to PB" would have been, and still is, appropriate.
With all due respect to CJ, she apparently just cut and pasted powerbattle's DD (see top sticky). Had she given credit to PB, as she should have, he would rightfully be receiving the praise she is currently enjoying. Props to PB for not calling out CJ himself. Not surprised after reading his posts. Class act.
The post in question that suggested that news was on the way next week has since been deleted. Thought it might be too good to be true. He didn't say he was a Bioadaptives employee, btw. He said he worked with Dr. Jacobs at some point. I was mildly suspicious of that, because as I understand it, he goes by Dr. Ted. Would be great if I was wrong. News next week would be spectacular of course.
Not starting a rumor, but Dr. Ted came to this company as a board member and was promoted to CEO. We're all aware of his advanced age. Could Dr. Yaguang Liu, or more likely, David Allen, both a part of the $570,000,000 Myopia and Presbyopia patent project be positioned to become the next CEO? https://stockhouse.com/news/press-releases/2023/03/30/bioadaptives-inc-announced-today-the-signing-of-a-license-for-eye-health-due-to#:~:text=LAS%20VEGAS%2C%20NV%2C%20March%2030%2C%202023%20%28GLOBE%20NEWSWIRE%29,for%20Eye%20Health%20due%20to%20Myopia%20and%20Presbyopia. Just throwing it out there. That would be an interesting announcement. David Allen has contacts all over the world due the organization he founded and leads, the American Botanical Drug Association. https://www.botanicaldrug.org/ Scroll down the botanical site to see their leadership team and all the countries represented. I can't verify, but Allen's World Wellness, LLC doesn't appear to exist anymore. Thoughts?
Wow... 4, that's impressive, PB. Sadly, there are many people who, despite being fluent in only English, can barely put a sentence together. 🙄
your pic - not you're pic - ugh, embarrassing
Not a big deal, but you're pic of David Allen is not the right guy.
https://www.botanicaldrug.org/
Scroll down to leadership team to see the real David Allen.
Lots of other interesting people on this team as well, btw.
Let the trend be your friend. Simple advice.